Note: Ingredients listed on restricted chemical lists
EC/CAS
93925-42-9
Name of the chemical
Silicic acid (H4SiO4), tetraethyl ester, reaction products with bis(acetyloxy)dibutylstannane
Concentration
N/A
General Information
Revision date
2020-06-10
Product name
Sikasil SG-500 (B)
supplier name
Sika Limited
Icons in SDS
Company Information
company name
Sika Limited
e-mail address of the competent person responsible for the Safety Data Sheet
EHS@uk.sika.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H315, H317, H318, H335
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
CLP CLASSIFICATION
Skin irritation, Category 2 H315: Causes skin irritation. Serious eye damage, Category 1 H318: Causes serious eye damage. Skin sensitisation, Category 1 H317: May cause an allergic skin reaction. Specific target organ toxicity - single ex- H335: May cause respiratory irritation. posure, Category 3, Respiratory system
2.2 Label elements
REGULATION (EC) No 1272/2008)
Signal word
Danger
Hazard statements
H315 Causes skin irritation. H317 May cause an allergic skin reaction. H318 Causes serious eye damage. H335 May cause respiratory irritation.
Prevention
P261 Avoid breathing dust/ fume/ gas/ mist/ va- pours/ spray. P264 Wash skin thoroughly after handling. P280 Wear protective gloves/ eye protection/ face protection.
Response
P304 + P340 + P312 IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER/ doctor if you feel unwell. P305 + P351 + P338 + P310 IF IN EYES: Rinse cautiously with water for several minutes. Remove con- tact lenses, if present and easy to do. Con- tinue rinsing. Immediately call a POISON CENTER/ doctor. P333 + P313 If skin irritation or rash occurs: Get medical advice/ attention.
Hazardous Ingredients
tetraethyl silicate N-[3-(triethoxysilyl)propyl]ethylenediamine
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
